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TheULK1 complex, consisting of the ULK1 protein ki-
nase itself, FIP200, Atg13, and Atg101, controls the
initiation of autophagy in animals. We determined
the structure of the complex of the human Atg13
HORMA (Hop1, Rev7, Mad2) domain in complex
with the full-length HORMA domain-only protein
Atg101. The two HORMA domains assemble with an
architecture conserved in the Mad2 conformational
heterodimer and theS. pombeAtg13-Atg101HORMA
complex.TheWFfingermotif that isessential for func-
tion in humanAtg101 is sequestered in a hydrophobic
pocket, suggesting that the exposure of this motif is
regulated. Benzamidine molecules from the crystalli-
zation solution mark two hydrophobic pockets that
are conserved in, andunique to, animals, and are sug-
gestive of sites that could interactwith other proteins.
These features suggest that the activity of the animal
Atg13-Atg101 subcomplex is regulated and that it is
an interaction hub for multiple partners.
INTRODUCTION
Macroautophagy (henceforward, autophagy) denotes a class
of bulk and selective cellular self-consumptive processes that
share conserved protein machinery (Mizushima and Komatsu,
2011; Reggiori and Klionsky, 2013). These processes include
starvation-induced bulk autophagy, the destruction of damaged
mitochondria by mitophagy, sequestration of cytosolic patho-
gens by xenophagy, and many others. There is intense interest
in therapeutic targeting autophagy in human cells for both acti-
vation and inhibition in cancer (Galluzzi et al., 2015), infectious
diseases (Manzanillo et al., 2013), and neurodegenerative dis-
eases (Pickrell and Youle, 2015). The divergent upstream trig-
gers of these various processes converge with the activation of
the kinase complex known as ULK1 (Unc51-like kinase auto-
phagy activating kinase 1) in animals and Atg1 in other eukary-
otes (Mizushima, 2010).
In humans and other animals, the ULK1 kinase complex con-
sists of ULK1 itself, FIP200, Atg13, and Atg101 (Mizushima,1848 Structure 23, 1848–1857, October 6, 2015 ª2015 Elsevier Ltd A2010). ULK1 (referred to in yeast and plants as Atg1) and
Atg13 are conserved throughout eukaryotes. FIP200 is unique
to animals and is thought to be functionally replaced by Atg11
and/or Atg17 in other eukaryotes (Mizushima, 2010). Atg101 (Ho-
sokawa et al., 2009a; Mercer et al., 2009) is found throughout
nearly all eukaryotes, with the exception of the budding yeasts
(Figure S1). The molecular weights of the subunits of the human
ULK1 complex sum to 377 kDa, and the apparent molecular
weight of the assembled complex is 3 MDa (Mizushima, 2010).
Of this considerable mass, experimental structural data for hu-
man or other metazoan ULK1 components are available only
for the catalytic kinase domain of ULK1 (Lazarus et al., 2015)
and for 12 residues of Atg13 that bind to LC3 (Suzuki et al.,
2013). These comprise just 33 kDa, or 8%, of the unique mass
of the complex.
Most of what is known about the organization of the human
ULK1 complex has been inferred from studies of its counterparts
in yeast (Hurley and Schulman, 2014). We previously determined
the structure of the Atg17 scaffold and showed that it was a
dimer with a double crescent or S shape (Ragusa et al., 2012).
Atg17 is constitutively bound to two other subunits, Atg29 and
Atg31 (Kabeya et al., 2009). Atg29 and Atg31 are unique to
budding yeast, while Atg101 is absent. The tips of the double
crescent bind to the intrinsically disordered C-terminal region
of Atg13 (Fujioka et al., 2014). An adjacent region of Atg13 binds
to the C-terminal EAT domain of Atg1 (Fujioka et al., 2014). The
Atg1 EAT domain can be subdivided into two MIT domains,
both of which bind to short MIM motifs in the C-terminal part
of Atg13 (Fujioka et al., 2014). The Atg1 EAT domain is a dimer
(Stjepanovic et al., 2014). The entire yeast Atg1 assembly forms
tetramers in solution, and a low-resolution solution structure of
the tetramer has been analyzed (Ko¨finger et al., 2015). The
goal of this study is to begin building up a similar picture of the
human ULK1 complex structure.
The N terminus of Saccharomyces cerevisiae Atg13 (Jao et al.,
2013) consists of a Hop1/Rev7/Mad2 (HORMA) domain (Aravind
and Koonin, 1998), and this domain appears to present in all
Atg13 orthologs. The S. cerevisiae HORMA domain has a puta-
tive phosphate binding site (Jao et al., 2013) that is important
for recruiting the membrane protein Atg9 (Suzuki et al., 2015b),
which recruits the autophagic PI 3-kinase complex (Jao et al.,
2013; Suzuki et al., 2015b). More recently, Atg101 has been pre-
dicted to consist in its entirety of a single HORMA domain and to
dimerize with Atg13 via this domain (Hegedus et al., 2014). Bothll rights reserved
Figure 1. Domain Structure and Ordered Regions of Atg13 and Atg101
(A) Schematic diagram of the domain structures of human Atg101 and Atg13. The HORMA domains of Atg101 and 13 are colored in green and cyan, respectively.
The boundaries of constructs we used in this study are highlighted in red. The LIR and MIM motifs of Atg13, which interact with LC3 and ULK1, respectively, are
colored blue.
(B) The purified Atg101-Atg13 complexes were analyzed by SDS-PAGE. Lane 1: Atg101(1–218)-Atg13(1–364); lane 2: Atg101(1–218)-Atg13(1–224), two bands
were overlapped; lane 3: Atg101(1–199)-Atg13(12–200).
(C, D) Deuterium uptake data for the Atg13-Atg101 complex. HDX-MS data are shown in heat map format, where peptides are represented using rectangular
strips above the protein sequence. Absolute deuterium uptake after 10 s and 30 s is indicated by a color gradient below the protein sequence. See also Figure S1.predictions have recently been confirmed (Suzuki et al., 2015a).
HORMA domain structure has been intensively studied for the
mitotic spindle checkpoint protein Mad2 (Chao et al., 2012;
Luo et al., 2002; Mapelli et al., 2007; Sironi et al., 2001), as well
as p31(comet) (Yang et al., 2007), Rev7 (Hara et al., 2010), and
HIM-3 and HTP-2 (Kim et al., 2014). The Mad2 HORMA domain
can interconvert between two different conformations, closed
(C) and open (O). The conformation is controlled in part by the
length and position of a loop known as the safety belt. C-Mad2
and O-Mad2 assemble into a 1:1 heterodimer, which has been
crystallized (Mapelli et al., 2007).
To obtain insight into the Atg13-Atg101 portion of the human
ULK1 complex, we co-expressed the two human proteins in in-
sect cells and determined their structure ab initio using Br sin-Structure 23, 1848–gle anomalous dispersion (SAD) phasing. As we were preparing
this article, the structure of the fission yeast (S. pombe) Atg13-
Atg101 subcomplex was reported at 3.0 A˚ resolution (Suzuki
et al., 2015a) and used as a basis to make predictions about
functional regions of the human proteins. This study identified
a WF finger as a key interaction motif on Atg101, a feature
conserved in humans. The sequences of the Atg13 and Atg101
portions of the structure are 21% and 25% identical, respec-
tively, between S. pombe and human. Compared with the
3.0-A˚ resolution S. pombe structure, the 1.6-A˚ resolution human
structure provides a detailed and accurate account of the inter-
actions that hold the complex together, shows that theWF finger
is subject to sequestration, and identifies potential animal-spe-
cific hydrophobic pockets at the subunit junction.1857, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1849
Figure 2. Structure Determination of the
Atg13-Atg101 Complex
(A) Br SAD synthesis displayed at a contour level
of 2s (magenta), with parts of Atg101 aA and Atg13
aC shown in green and cyan, respectively.
(B) The omit map corresponding to the region
shown in (A) is displayed at a contour level of 2s
(magenta).
(C) The omit map in the safety belt region is dis-
played at a contour level of 1s (magenta), with the
safety belt colored red.
(D) The overall structure of the Atg101 and Atg13
HORMA dimer shown in a ribbon representation
colored as above. The aA-aB connector of Atg13,
including b20, is colored orange.
(E) Side-by-side comparison of Atg101-Atg13,
SpAtg101-Atg13, and C-Mad2-O-Mad2. From
left to right: Atg101-Atg13 (green and cyan),
SpAtg101-Atg13 (yellow and teal), and C-Mad2-
O-Mad2 (purple and orange). See also Figures S2
and S3.RESULTS
Mapping the Order/Disorder Boundaries of Atg13 and
Atg101
Atg13 contains a mixture of ordered and intrinsically disordered
regions. Human Atg13 has marginal sequence homology to its
structurally characterized S. cerevisiae (Jao et al., 2013) and
S. pombe (Suzuki et al., 2015a) orthologs (11.7% and 19% iden-
tity, respectively). Therefore, we considered the precise bound-
ary between the ordered and intrinsically disordered portions of
Atg13 to be uncertain. We found that it was not possible to ex-
press the Atg13 HORMA domain in isolation, suggesting that
Atg13 is not stable in the absence of Atg101. We therefore co-
expressed full-length Atg101 with an Atg13 construct 1–364,
which includes the HORMA domain and additional 150 resi-
dues beyond the expected C-terminal boundary of the HORMA
domain (Figures 1A and 1B).
We used hydrogen-deuterium exchange coupled to mass
spectrometry (HDX-MS) (Engen, 2009) to probe the flexibility of1850 Structure 23, 1848–1857, October 6, 2015 ª2015 Elsevier Ltd All rights reservedthe proteins. We incubated the samples
in D2O for 10 s or 30 s, reasoning that
intrinsically disordered regions exchange
completely within 30 s. Identified peptic
peptides from Atg13 (Figure 1C) and
from Atg101 (Figure 1D) covered 83%
and 97% of the respective sequences.
Ala188 of Atg13 was found to be the
most C-terminal of the well-ordered resi-
dues. We also determined that the first
11 residues of Atg13 were disordered
(Figure 1C). The analysis showed that
most of Atg101 was well ordered, except
for the extreme C terminus. We estab-
lished Phe194 as the most C-terminal
well-ordered residue. Residues 196–198
showed some protection at 10 s, but
none at 30 s. The final residues 199–218of Atg101, which includes the HORMA domain safety belt, ap-
peared to be completely unstructured.
Crystal Structure of the Human Atg13-Atg101 Complex
We determined the structure of the human Atg13-Atg101 com-
plex by SAD from solvent Br ions (Figures 2A–2C). We went
on to refine the native Atg13-Atg101 complex structure to
1.6 A˚ resolution. The structures of the two proteins are well
defined, with both chains traceable from start to finish without
breaks. Hydrogen positions were refined, as well as alternative
conformations of side chains where present. Every residue of
Atg101 was visualized, and only the final five residues of the
Atg13 construct were absent from the electron density. The
entire safety belt of the Atg13 HORMA domain was visualized,
the first time this has been possible for any of the Atg13 HORMA
structures.
The human Atg13 structure contains an extensive connector
between aA and aB (residues 33–58; Figures 2D and S1A), which
was not visualized in the yeast structures. This region was
Figure 3. The Atg13-Atg101 Interface
(A) Overall view of the interface in a surface and
ribbon model. Insets indicate close-ups of the
indicated regions of the interface. Key residues of
the Atg101 surface are colored red, while those of
Atg13 are in blue.
(B) Overall view of the interaction of the key resi-
dues on the interface.
(C) Detail of the hydrophobic core and the
hydrogen bond (dotted line) between Atg101His31
and Atg13 Ser127.
(D) Detail of hydrogen bonds (dotted lines) be-
tween Atg101 Asp54 and Atg13 Arg133, and
packing of Atg13 b20 against Atg101 b2.
(E) HDX-MS heatmap data at 10 s overlaid onto the
crystal structure of the Atg13-Atg101 complex.
Absolute deuterium uptake is indicated by the
color gradient.visualized in its entirety in the electron density despite its low de-
gree of protection as assessed by HDX. This region includes the
unique b20 strand, which forms an inter-domain b sheet with b2
and b3 of Atg101 (Figure 2D).
The two HORMA domains dimerize in the same orientation as
in the C-Mad2-O-Mad2 conformational dimer (Mapelli et al.,
2007) and in the S. pombe Atg13-Atg101 complex (Suzuki
et al., 2015a) (Figure 2E). The entire dimer can be superimposed
on the Mad2 conformational dimer with a root-mean-square
deviation (rmsd) of 2.75 A˚ for 274 Ca positions. In the case of
the S. pombe Atg13-Atg101 dimer, the values are 1.74 A˚
for 270 residues. The interface buries a total of 1523 A˚2 of sur-
face area.
The Atg13 side of the interface is centered on aC and the aA-
aB connector, including b20 (Figure 3A). The Atg101 side con-
sists of both aA and aC and the small b2-b3 sheet. Buried polar
interactions form a prominent part of the Atg13 aC-Atg101 aA
interface (Figures 3B–3D). Atg13 Ser127 forms a 2.8 A˚ hydrogen
bond with Nε of Atg101 His31 (Figure 3C). These residues areStructure 23, 1848–1857, October 6, 2015 ªconserved in S. pombe and the same
interaction probably occurs in the
S. pombe complex. The analysis of the
3.0-A˚ resolution fission yeast structure
assigned the corresponding His30 of
Atg101 to interact with Thr183 of Atg13
(Suzuki et al., 2015a), which involves an
unfavorable geometry with the Ser hy-
droxyl group at a 90 angle with respect
to the plane of the His imidazole. This dif-
ference in the structures likely reflects the
difference in resolution rather than a true
difference between the species. A buried
salt bridge is formed between Atg13 aC
Arg133 and Atg101 Asp54 of the b20- b2
loop. This interaction is bidentate and
the shortest heteroatom distance is
2.64 A˚ (Figure 3D). These residues are
not present in S. pombe but are highly
conserved among animals (Figures S1A
and S1B). This suggests that this saltbridge is likely to contribute substantially to the stability and
specificity of animal Atg13-Atg101 complexes.
The WF finger was identified as a functionally important motif
of Atg101 on the basis of its high solvent accessibility in the
S. pombe structure. In the crystal lattice of the S. pombe com-
plex, the WF motif is buried in a lattice contact, thus stabilizing
what would otherwise be an unfavorable degree of solvent expo-
sure for such hydrophobic residues. The structure of human
Atg101 alone (Michel et al., 2015), confirms that the WF motif
can exist in an out conformation in the human protein. In our
structure, the Atg101 WF motif residues Trp110 and Phe112
are folded back onto the Atg101 HORMA domain. These two
side chains pack against one another, Ile117, and the aliphatic
parts of Gln104, Lys107, and Arg109 (Figure 4).
The Human Atg13-Atg101 Interface
Weprobed the role of various parts of the Atg13-Atg101 interface
using mutational analysis. Because Atg13 is not stable when
expressed alone, experiments were designed in the context of2015 Elsevier Ltd All rights reserved 1851
Figure 4. An Inactive Conformation of the WF Finger
(A) Upper panel: left to right: Cartoon model of the WF fingers from Atg101-
Atg13 (closed conformation), Atg101 alone (RCSB entry 4WZG) (open), and
SpAtg101-Atg13 (4YK8) (open). Lower panel: left, comparison of theWF finger
of Atg101-Atg13 and SpAtg101-Atg13; right, Atg101-Atg13 and Atg101 alone.
The WF finger from human Atg101 is colored purple while that of fission yeast
is colored red.
(B) TheWF finger is partially buried by the residues around it. Cartoon (left) and
surface representations (right) are shown here. Key residues are shown in a
stick model.co-expression of the HORMA fragments in HEK293 cells.
Because the interfacial area is large, we expected that the inter-
action would be relatively robust to perturbation by single muta-
tions. We therefore designed multiple mutants to overcome this
potential obstacle. Mutants were assessed both by the ability
of GST-Atg13-HORMA to pull down Atg101 and by the ability of
Strep-Atg101-HORMA to pull down Atg13 (Figures 5A and 5B).
The key polar residues of Atg13, Ser127, and Arg133, were
mutated in a role reversal to the interaction partners in Atg101,
His and Asp, respectively. The S127H/R133Dmutant completely
blocked complex formation as judged by the absence of an
Atg13 band in the Strep pull-down (Figure 5B). In the GST pull-
down, neither Atg13 nor Atg101 bands are visible, consistent
with the expectation that breaking up the complex would desta-
bilize Atg13 and so prevent its expression.1852 Structure 23, 1848–1857, October 6, 2015 ª2015 Elsevier Ltd ATo test the role of the Atg13 aA-aB connector, the 13 residues
37–49 were replaced with a tetra-Gly-Ser linker that was de-
signed to be long enough to span the gap from residues 36 to
50. This loop was found to be non-essential for complex forma-
tion. This is consistent with the observation from HDX that this
region exchanges rapidly, suggesting that it contributes margin-
ally to overall stability.
The hydrophobic portion of the Atg13 aC interface was probed
with the mutation I131D/V134D. This mutation sharply reduced
complex formation by both assays (Figures 5A and 5B). The
S. pombe mutant T183R/L187R probed the same region of that
structure, with the same consequence. When combined with
the aC polar mutation S127H/R133D, or with both the polar
mutation and the connector deletion, binding was eliminated
completely (Figures 5A and 5B). On the Atg101 side of the same
contact, the Atg101 aC hydrophobic interface mutant I152D/
I153D/V156D completely eliminated the complex, consistent
with the central role for these residues in the heart of the interface.
On the Atg101 side of the polar core, the single polarmutations
H31S andD54R had little impact on complex stability (Figures 5A
and 5B). The H31S effect is consistent with the lack of effect of
the double large-to-small mutation F29A/H30A in the S. pombe
complex. In S. pombe, the more drastic change F29R/H30R
did disrupt the complex, consistent with an important role for
these residues. Combining the D54R mutation with the nearby
T49A/T52A pair had a marked effect on complex formation,
consistent with an important role for this part of the interface.
Likewise, the double mutant H31S/D54R markedly destabilized
the complex, confirming the centrality of the polar core of the
interface from the Atg101 side as well as the Atg13 side of the
interface.
Benzamidine Binding Sites Mark Hydrophobic Pockets
In the crystallographic mode of fragment-based drug discovery,
targets are intentionally co-crystallized with very low molecular
weight compounds to identify potential sites for inhibitor binding.
This information can be built upon for drug discovery. Crystals of
the human Atg13-Atg101 complex were obtained using 0.5 M
benzamidine as an additive. This fortuitously revealed to us the
presence of five hydrophobic pockets of potential functional in-
terest (Figure 6A). One benzamidine site is located near the in
state WF finger (Figure 6A) and participates in a lattice contact.
This molecule is likely the one responsible for stabilizing the
crystal. The finding that benzamidine interacts with a previously
identified functional site, the WF finger, validates the concept
that benzamidine binding is probing potentially significant sites.
Of the remaining four sites, two caught our attention because
they are surrounded by conserved residues in the animal se-
quences. Both of these sites are formed at the Atg13-Atg101
interface and are composed of residues from both proteins.
Site 1 consists of Atg13 Ser114, Tyr115, and Tyr118; and
Atg101 Tyr45 and Ile47 (Figure 6B). One of the benzamidine ni-
trogens is bound by the main chain carbonyl of Atg101-Tyr45.
Site 2 is formed by Atg13 Tyr138 and the aliphatic parts of
Arg139, Arg142, and Lys143; and Atg101 Asp56 and Thr63 (Fig-
ure 6C). Thr63 is not just part of the pocket. This Thr is also
directly involved in the interface with Atg13 and the mutant
T63R was tested previously. It shares this characteristic with
most of the other benzamidine 1 and 2 pocket residues. Thell rights reserved
Figure 5. Mutational Analysis of the Atg13-
Atg101 Interface
HEK293 cells were cotransfected with mutant
variants of GST-Atg13 and Strep-Atg101 HORMA
domains. Cell lysates were precipitated with either
glutathione Sepharose (A) or Strep-Tactin (B)
beads. The resulting precipitates were examined
by SDS-PAGE. WT, wild-type.mutation T63R has a modest effect on both complex formation
and autophagic function (Suzuki et al., 2015a). The dual role of
Thr63 illustrates that it may be difficult to mutationally deconvo-
lute functional roles of the pockets that are distinct from their
roles in the interface.
DISCUSSION
Adding the present structure of the human Atg13-Atg101 com-
plex to the previously determined structure of the ULK1 catalytic
domain (Lazarus et al., 2015), the field has nowmade substantial
inroads into visualizing the ordered portions of the human ULK1
complex at high resolution. The intense interest in targeting auto-
phagy in human cells in cancer, neurodegeneration, aging, and
infectious diseases places a premium on accurate data on the
structure of human complexes such as provided here.
The gross features of the Atg13-Atg101 HORMA heterodimer
are similar in S. pombe and human, with both, in turn, similar to
theC-Mad2-O-Mad2 dimer. In bothS. pombe and human, Atg13
and Atg101 are in the C-Mad2 and O-Mad2 conformations,
respectively. Both dimerize through an interface involving the
aC helices of both subunits. The human Atg13-Atg101 complex
has a polar core at its interface that includes a buried salt bridgeStructure 23, 1848–1857, October 6, 2015 ªat its heart. The salt bridge is unique to the
animal Atg13-Atg101 complex, which
was not predicted, and perhaps could
not have been predicted from the
S. pombe structure. A buried Ser-His
hydrogen bond is nearby in the polar
core. While the corresponding residues
are present in the S. pombe structure,
their mutual interaction was not identified,
probably because of the lower resolution
of that structure. Thus, the present struc-
ture provides the first reliable account of
the polar core at the heart of the animal
Atg13-Atg101 interface.
The human complex structure sug-
gests that the newly discovered WF
finger of Atg101 (Suzuki et al., 2015a) is
subject to regulation. In the S. pombe
complex and in the isolated human
Atg101 structure (Michel et al., 2015),
the WF finger projects outward from the
rest of Atg101. In the present structure,
it is folded back on the HORMA domain.
This suggests that the WF finger is not
always in a position to bind its as yet un-identified interaction partners. The conformation seen in our
structure would correspond to an inactive state of the motif.
Just as it remains to be determined what the WF finger binds
to, it also remains to be discovered how the accessibility of
the WF finger is switched on and off.
Several hydrophobic pockets were identified by benzamidine
molecules, of which two caught our attention because of their
high degree of conservation. These pockets are lined with resi-
dues that are well conserved in the Atg13 and Atg101 proteins
of animals but largely missing in fission yeast (Figure 6D). The ex-
istence of these pockets could not have been predicted from the
fission yeast structure. The high degree of conservation of the
residues in these pockets and their hydrophobicity seems
consistent with a functional role. It is intriguing that the pockets
are formed at the junction between Atg13 and Atg101, which is
consistent with the essential roles of both Atg13 (Chang and
Neufeld, 2009; Ganley et al., 2009; Hosokawa et al., 2009b;
Jung et al., 2009) and Atg101 (Hosokawa et al., 2009a; Mercer
et al., 2009) in autophagy in animal cells.
Intrinsically disordered regions (IDRs) are abundant in auto-
phagy proteins (Baskaran et al., 2014; Hurley and Schulman,
2014; Mei et al., 2014; Popelka et al., 2014). The presence of
so much intrinsic disorder implies the need for many IDR binding2015 Elsevier Ltd All rights reserved 1853
Figure 6. Benzamidine Binding Sites Mark
Hydrophobic Pockets
(A) Overall view of the locations of five benzamidine
molecules. The complex of Atg101 and Atg13 is
shown in a surface model and benzamidines are
shown as a stick model. TheWF finger is indicated.
(B, C) Details of the environment of benzamidine
molecules 1 and 2 are shown in cartoon (left) and
surface (right) models. Benzamidines and high-
lighted residues are shown in a stick model.
(D) (Left) The electrostatic surface was generated
at a saturating color level of ±5 kT/e. (Right) Resi-
dues located in the positive groove are shown in a
stick model. The dotted circle indicates the region
of the basic groove between the subunits.sites on the ordered components of the machinery. Those
ordered components containing multiple binding pockets could
function as interaction hubs, potentially bringing together multi-
ple IDRs. Our observations suggest that in animal cells, the
Atg13-Atg101 HORMA heterodimer is likely to function as just
such a hub.
Several HORMA domains have been shown to bind peptides
in the C conformation between the edge of the main b sheet
and the safety belt (Hara et al., 2010; Kim et al., 2014;
Luo et al., 2002; Sironi et al., 2002). Atg13-HORMA has consis-
tently been observed in the C conformation in structures of
the S. cerevisiae, S. pombe, and now human proteins. The
S. cerevisiae structure contains a phosphate binding site (Jao
et al., 2013) that is formed in part by the safety belt. The site is
important for recruitment of Atg9 (Suzuki et al., 2015b). Atg9 is1854 Structure 23, 1848–1857, October 6, 2015 ª2015 Elsevier Ltd All rights reservedthe sole integral membrane protein of
the core autophagy machinery and is
important in the initiation of autophagy in
budding yeast. It seems likely that in
S. cerevisiae, a peptide region of Atg9
binds to Atg13-HORMA in the canonical
mode. However, this binding occurs
through a non-conserved part of the
N-terminal domain of S. cerevisiae Atg9,
and this interaction mode is probably
confined to budding yeast.
In human Atg13-HORMA, the safety
belt is only 13 residues long, compared
with 25–35 residues in both budding and
fission yeast Atg13 and other HORMA
proteins. The structure shows that the hu-
man Atg13 safety belt is pinned to the rest
of the domain through several large hy-
drophobic residues. This leads us to infer
that the canonical peptide binding func-
tion of the safety belt region of HORMA
domains has been lost in animal Atg13
proteins. With respect to Atg101, the
S. pombe protein is locked in the O
conformation because its b5-aC linker
contains only five residues, which is too
short to reach the C state. The linker in hu-
man Atg101 is 11 residues long and inprinciple might allow for conversion. However, human Atg101
is seen in the O conformation whether bound to Atg13 or free.
This is consistent with the idea that human Atg101 is also locked
in the O state. Thus is seems that the HORMA domains of auto-
phagy in animals are outliers, in that they are unlikely to bind pep-
tides in the canonical mode seen for other HORMA proteins.
The other notable property of HORMA domains, at least in the
case of Mad2, is the ability to interconvert between C and O con-
formations and so heterodimerize (Mapelli et al., 2007). It ap-
pears that the ability to form a C and O state heterodimer, and
not safety belt peptide binding, is the property that is shared be-
tween animal Atg13 and Atg101 and other HORMA proteins.
Given that budding yeasts are an outlying branch in the phylog-
eny of Atg13 and lack Atg101 entirely (Figure S1), we speculate
that the autophagy HORMA domains evolved from a single
Figure 7. Scheme for the Evolution of Atg13
and Atg101
A speculative scheme for the evolution of animal
Atg13 and Atg101, and budding Atg13 from an
ancestral S. pombe-like Atg13-Atg101 pair.Mad2-like ancestor as follows. The first changewould have been
gene duplication, with a stable C and O heterodimer taking the
place of the ancestral conformational heterodimer of chemically
identical subunits. This would have led to an ancestral Atg13-
Atg101 pair similar to that of S. pombe (Figure 7). In the evolution
of budding yeast, Atg101 was lost. Budding yeast Atg13 evolved
to be stable in the absence of Atg101 and acquired a safety belt
phosphate binding site. This additional interaction site might
compensate in part for interactions that were lost with the disap-
pearance of Atg101. The structurally unrelated Atg29 and Atg31
proteins of the budding yeast Atg1 complex may also have a role
in functional compensation. In the evolution of the animal Atg13-
Atg101 pair, the Atg13 safety belt peptide binding site appears to
have been lost when this loop was shortened to the minimum
necessary to connect b6 to b7. More was gained than lost, how-
ever, with the acquisition of hydrophobic sites 1 and 2, and the
electropositive nature of the groove between the two proteins.
The new structures of Atg13-Atg101 have revealed several
novel interaction sites: the conserved WF finger and the ani-
mal-specific hydrophobic pockets. This begs the question as
to what the interaction partners are. Obvious candidates include
the C-terminal portion of Atg13 itself and other extended regions
of the ULK1 complex, such as the long linker between the
catalytic and EAT domains of ULK1 itself. Other members of
the autophagy machinery would also be candidates, for
example, the class III phosphatidylinositol 3-phosphate kinase
complex I, which is rich in IDRs (Baskaran et al., 2014). The other
obvious class of associating proteins would be the many sub-
strates of ULK1. The catalytic domain of ULK1 preferentially
phosphorylates sequences containing hydrophobic residues at
the 3 and +1 positions (Egan et al., 2015). Clearly, this prefer-
ence alone is not enough to confer the specificity needed for
accurate ULK1 signaling. Interactions with other sites, such as
provided by the Atg13-Atg101 HORMA dimer, would be an
attractive mechanism for enhancing the specificity of substrate
recognition.
METHODS
Cloning and Protein Purification
Human Atg13-Atg101 constructs were expressed in Spodoptera frugiperda
(Sf9) cells. DNAs coding for human Atg13 and Atg101 were subcloned intoStructure 23, 1848–1857, October 6, 2015pFastBac Dual following the polyhedron and
p10 promoters, respectively. Baculoviruses were
generated in Sf9 cells with the bac-to-bac system
(Life Technologies). Recombinant Atg13 was ex-
pressed with an N-terminal GST tag followed by
a tobacco etch virus (TEV) protease cleavage
site, and Atg101 was expressed either with or
without a His8 tag. Cells were infected and
harvested after 48 hr to 72 hr. Cells were pelleted
at 2000 3 g for 20 min at 4C. Cell pellets were
lysed in 25 mM Tris-HCl (pH 8.0), 150 mM NaCl,
0.5 mM TCEP-HCl, and protease inhibitors(Roche) using ultrasonication. The lysate were centrifuged at 25, 000 3 g
for 1 hr at 4C. The supernatant was bound to glutathione Sepharose
(GS4B) at 4C overnight, eluted, and applied to a Hi Trap Q HP column
(GE Healthcare). Hi Trap Q peak fractions were collected and digested
with TEV protease at 4C overnight. The TEV-treated protein solution was
further purified with a Hi Trap S HP column and a Superdex 75 16/60 column
(GE Healthcare) equilibrated with 25 mM Tris-HCl (pH 8.0), 150 mM NaCl,
0.5 mM TCEP-HCl. Peak fractions were collected and flash-frozen in liquid
N2 for storage.
HDX-MS Experiments
Amide HDX-MS was initiated by a 20-fold dilution of 40 mM Atg101-Atg13
complex (consisting of full-length Atg101 and residues 1–364 of Atg13) into
a D2O buffer containing 25 mM Tris-HCl (pD 8.0), 150 mM NaCl, and 5 mM
DTT at 30C. After intervals of 10 s and 30 s, exchange was quenched at
0C with the addition of ice-cold quench buffer (400 mM KH2PO4/H3PO4
[pH 2.2]). Quenched samples were injected onto a high-performance liquid
chromatography (HPLC) (Agilent 1100; Agilent Technologies) with in-line
peptic digestion and desalting. Desalted peptides were eluted and directly
analyzed by an Orbitrap Discovery mass spectrometer (Thermo Scientific).
Peptide identification was done by running tandemMS/MS experiments. Pep-
tides were identified using PEAKS Studio 7 (www.bioinfor.com). Initial mass
analysis of the peptide centroids was performed using HDExaminer 1.4.3
(Sierra Analytics) followed by manual verification of every peptide. The
deuteron content was adjusted for deuteron gain/loss during digestion and
HPLC. Both nondeuterated and fully deuterated complex were analyzed. Fully
deuterated samples were prepared by three cycles of drying and resolubiliza-
tion in D2O and 6 M guanidinium hydrochloride.
Crystallization of the Human Atg13-Atg101 Complex
The Atg13 (residues 12–200) and Atg101 (residues 1–198) complex (Figures 1A
and 1B) was concentrated to 6 mg/ml with a 10-kDa cutoff centrifugal filter
(Millipore). Crystals were grown by hanging-drop vapor-diffusion at 19C.
The protein solution was mixed with well buffer composed of 19% polyeth-
ylene glycol 3350, 0.5 M benzamidine, and 0.2 M lithium citrate. Crystals
appeared in 2 days and grew to full size (0.05 3 0.1 3 0.3 mm) in 5–7 days.
Crystals were flash-frozen with liquid nitrogen in the well solution.
Data Collection and Structure Determination
Diffraction datawere collected at BL8.3.1, Advanced Light Source (ALS), LBNL.
Native crystals diffracted to 1.63 A˚, and data were collected at l = 1.07207 A˚.
Native crystals were soaked in cryo-protectant buffer supplemented with
0.5MNaBr for10sand thenwereflash-frozen in liquidnitrogen.ABrSADdata-
set (Dauter and Dauter, 2001) was collected at l = 0.92000 A˚. All datasets were
processed with HKL2000 (HKL Research). Data collection and processing
statistics are given in Table 1. Br ion positions were identified and phases
calculated using SHELXC/D/E (Schneider and Sheldrick, 2002). Model building
and refinement were carried out with ARP/wARP (Langer et al., 2008), Cootª2015 Elsevier Ltd All rights reserved 1855
Table 1. Statistics of Crystallographic Data Processing and
Refinement
Native Br SAD
Data collection
Space group C2 C2
Cell dimensions
a, b, c (A˚) 67.72, 64.45, 94.12 67.66, 67.76, 93.83
a, b, g () 90.000, 97.54, 90.000 90.00, 97.48, 90.00
Wavelength (A˚) 1.07207 0.92000
Resolution (A˚) 50.00–1.63
(1.69–1.63)
50.000–1.93
(2.00–1.93)
No. of reflections 49,908 29,890
Completeness (%) 100.0 (100.0) 100.0 (99.0)
Redundancy 5.3 (3.9) 4 (3.8)
Rsym 0.092 (0.486) 0.095 (0.942)
<I>/<s(I)> 12.89 (3.45) 14.4 (1.37)
CC1/2 0.872 0.640
Refinement
Resolution (A˚) 46.65–1.63 (1.66–1.63) —
Rwork/Rfree (%) 17.59/19.03 —
Average B factor (A˚)
Atg101-Atg13 37.242/47.063 —
Ligand (benzamidine) 56.457 —
Rmsd from ideality
Bond length (A˚) 0.0059 —
Bond angle () 0.996 —
Ramachandran plot (%)
Favored 97.6 —
Allowed 2.4 —
Outlier 0 —
CC1/2, Pearson’s correlation coefficient between average intensities from
two arbitrarily divided half-data sets.(Emsley et al., 2010), REFMAC5 (Murshudov et al., 1997) and PHENIX (Adams
et al., 2010).
Pull-Down Assays
For pull-down experiments, Atg13 and Atg101 HORMA domains were subcl-
oned into the pCAG vectors with appropriate affinity tags. Equal amounts of
human Atg13 and Atg101 plasmids were transfected into HEK293 GnTI cells
adapted for suspension. Cells were grown in Freestyle media (Invitrogen) sup-
plemented with 1% FBS (Invitrogen) at 37C, 80% humidity, 5% CO2, and
rocked at 140 rpm. After 3 days, cells were harvested and lysed in ice-cold
lysis buffer (25 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.5 mM TCEP-HCl, 1%
Triton X-100, and one tablet of EDTA-free protease inhibitors [Roche] per
25 ml). The soluble fractions of cell lysates were isolated by centrifugation at
16,000 3 g for 10 min. The lysates were added to 20 ml of pre-equilibrated
glutathione Sepharose 4B (GE Healthcare Life Sciences) or Strep-Tactin
Superflow (IBA GmbH) beads, and incubated at 4C for 30 min. The beads
were then washed three times with 500 ml of wash buffer (25 mM Tris-HCl
[pH 8.0], 150 mM NaCl, 0.5 mM TCEP-HCl), and the bound proteins were de-
natured by the addition of 20 ml of sample buffer and boiling for 5 min, resolved
by SDS-PAGE.ACCESSION NUMBERS
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